人々
社員こそが当社の最も貴重な財産であり、その資質、創造性、そして献身的な姿勢は、当社の成功に不可欠な要素です。
人物を検索
社員に関する最新情報
January 23, 2026
In the News
Kyle Faget Assesses Latest Federal Health Care Funding Actions
Foley & Lardner LLP partner Kyle Faget assessed the U.S. Department of Health and Human Service's latest federal health care funding actions in Inside Health Policy.
January 23, 2026
Deals and Wins
Foley Represents TCGX as Investor in $287M Series D1 Financing for CORXEL
Foley & Lardner LLP represented TCGX Crossover (TCGX) as an investor in the $287 million Series D1 financing for CORXEL, a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for patients with cardiometabolic conditions around the world.
January 23, 2026
Deals and Wins
Foley Represents DLB in Sale of Majority Stake to Accenture
Foley & Lardner LLP represented DLB Associates and its affiliated companies (collectively “DLB”), an industry leader and trailblazer in engineering and consulting services for data centers and related mission critical facilities, in the sale of a majority stake to Accenture (NYSE: ACN).